These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17556715)
1. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Ma Y; HayGlass KT; Becker AB; Fan Y; Yang X; Basu S; Srinivasan G; Simons FE; Halayko AJ; Peng Z Am J Respir Crit Care Med; 2007 Sep; 176(5):439-45. PubMed ID: 17556715 [TBL] [Abstract][Full Text] [Related]
2. Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice. Ma Y; Hayglass KT; Becker AB; Halayko AJ; Basu S; Simons FE; Peng Z Allergy; 2007 Jun; 62(6):675-82. PubMed ID: 17508973 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice. Zhou G; Ma Y; Jia P; Guan Q; Uzonna JE; Peng Z Vaccine; 2010 Feb; 28(7):1838-46. PubMed ID: 20005853 [TBL] [Abstract][Full Text] [Related]
4. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model. Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma. Wang Y; McCusker CT Clin Exp Allergy; 2005 Aug; 35(8):1104-11. PubMed ID: 16120094 [TBL] [Abstract][Full Text] [Related]
7. A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based virus-like particle vaccine in a mouse asthma model. Ma Y; Ma AG; Peng Z Vaccine; 2007 Nov; 25(47):8091-9. PubMed ID: 17935839 [TBL] [Abstract][Full Text] [Related]
8. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma. Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287 [TBL] [Abstract][Full Text] [Related]
9. Co-administration of vaccination with DNA encoding T cell epitope on the Der p and BCG inhibited airway remodeling in a murine model of chronic asthma. Kim CH; Ahn JH; Kim SJ; Lee SY; Kim YK; Kim KH; Moon HS; Song JS; Park SH; Kwon SS J Asthma; 2006; 43(5):345-53. PubMed ID: 16801138 [TBL] [Abstract][Full Text] [Related]
10. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. Vissers JL; van Esch BC; Hofman GA; Kapsenberg ML; Weller FR; van Oosterhout AJ J Allergy Clin Immunol; 2004 Jun; 113(6):1204-10. PubMed ID: 15208606 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-13 peptide kinoid vaccination attenuates allergic inflammation in a mouse model of asthma. Jing Q; Yin T; Wan Y; Shi H; Luo S; Li M; Zhang H; He H; Liu S; Li H; Wei Y; Yang L Int J Mol Med; 2012 Sep; 30(3):553-60. PubMed ID: 22735668 [TBL] [Abstract][Full Text] [Related]
12. Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma. Janssen EM; Wauben MH; Jonker EH; Hofman G; Van Eden W; Nijkamp FP; Van Oosterhout AJ Am J Respir Cell Mol Biol; 1999 Jul; 21(1):21-9. PubMed ID: 10385589 [TBL] [Abstract][Full Text] [Related]
13. Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration. Wells JW; Cowled CJ; Giorgini A; Kemeny DM; Noble A J Allergy Clin Immunol; 2007 Jan; 119(1):226-34. PubMed ID: 17208606 [TBL] [Abstract][Full Text] [Related]
14. Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation. Long Q; Huang W; Yao Y; Yang X; Sun W; Jin X; Li Y; Chu X; Liu C; Peng Z; Ma Y Hum Vaccin Immunother; 2014; 10(8):2303-11. PubMed ID: 25424936 [TBL] [Abstract][Full Text] [Related]
15. Establishing the phenotype in novel acute and chronic murine models of allergic asthma. Fernandez-Rodriguez S; Ford WR; Broadley KJ; Kidd EJ Int Immunopharmacol; 2008 May; 8(5):756-63. PubMed ID: 18387519 [TBL] [Abstract][Full Text] [Related]
17. Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma. Kim TB; Kim SY; Moon KA; Park CS; Jang MK; Yun ES; Cho YS; Moon HB; Lee KY Clin Exp Allergy; 2007 Nov; 37(11):1709-19. PubMed ID: 17877757 [TBL] [Abstract][Full Text] [Related]
18. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents. Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197 [TBL] [Abstract][Full Text] [Related]
19. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Kim DY; Ryu SY; Lim JE; Lee YS; Ro JY Eur J Pharmacol; 2007 Feb; 557(1):76-86. PubMed ID: 17169357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]